Form D · Other
Model Medicines, Inc.
San Diego, CA · CIK 0001892786
Offering snapshot reported Oct 21, 2026 · SEC filing
- Reported sold
- $5.12M Offering amount: $8M
- Investors reported
- 37 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 15, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 21, 2026 | Initial | $5,115,268 | No comparison | 37 | SEC filing |
| Nov 14, 2025 | Initial | $3,260,000 | No comparison | 10 | SEC filing |
| Oct 15, 2024 | Initial | $14,754,032 | No comparison | 43 | SEC filing |
| Feb 7, 2024 | Initial | $950,000 | No comparison | 10 | SEC filing |
| Nov 9, 2021 | Initial | $3,500,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-602012
Source: Form D, filed Oct 21, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Marlon Evans | Director, Executive |
| Daniel Haders | Executive |
| Kip Quackenbush | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
5120 Shoreham Place Suite 285
San Diego, CA, 92122
San Diego, CA, 92122